Decibel Therapeutics, Inc.
News
Decibel Therapeutics' CVR Appears Around Fair Value
SeekingAlpha Decibel Therapeutics' CVR Appears Around Fair Value...\n more…
Regeneron (REGN) Gains 13% in 1 Month on FDA Nod For Eylea HD
Zacks Investment Research Regeneron (REGN) gains 13% in a month on the FDA's approval of a higher dose of Eylea and other positive updates.\n\n It has been an eventful month for Regeneron Pharmaceuticals, Inc. REGN, which managed to reverse its trajectory in the year so far with the recent FDA approval of a higher dose of ...\n more…
Decibel Therapeutics (NASDAQ:DBTX) Cut to "Neutral" at HC Wainwright
Ticker Report HC Wainwright lowered shares of Decibel Therapeutics (NASDAQ:DBTX Free Report) from a buy rating to a neutral rating in a research report released on Wednesday, Marketbeat.com reports. Decibel Therapeutics Stock Performance Shares of NASDAQ DBTX opened at $5.11 on Wednesday. The firm has a ...\n more…
Decibel Therapeutics (NASDAQ:DBTX) Stock Rating Lowered by Robert W. Baird
Ticker Report Decibel Therapeutics (NASDAQ:DBTX Get Free Report) was downgraded by analysts at Robert W. Baird from an outperform rating to a neutral rating in a report issued on Thursday, MarketBeat reports. They currently have a $5.25 target price on the stock, down from ...\n more…
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTG, DBTX
Globe Newswire NEW YORK, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Computer Task Group, Inc. (NASDAQ: CTG)s sale ...\n more…